Suppr超能文献

人类错配修复系统通过从滞后链上去除更多的错配来平衡两条链之间的突变率。

Human mismatch repair system balances mutation rates between strands by removing more mismatches from the lagging strand.

机构信息

Institute for Information Transmission Problems of the Russian Academy of Sciences (Kharkevich Institute), Moscow 127994, Russia.

Lomonosov Moscow State University, Moscow 119234, Russia.

出版信息

Genome Res. 2017 Aug;27(8):1336-1343. doi: 10.1101/gr.219915.116. Epub 2017 May 16.

Abstract

Mismatch repair (MMR) is one of the main systems maintaining fidelity of replication. Differences in correction of errors produced during replication of the leading and the lagging DNA strands were reported in yeast and in human cancers, but the causes of these differences remain unclear. Here, we analyze data on human cancers with somatic mutations in two of the major DNA polymerases, delta and epsilon, that replicate the genome. We show that these cancers demonstrate a substantial asymmetry of the mutations between the leading and the lagging strands. The direction of this asymmetry is the opposite between cancers with mutated polymerases delta and epsilon, consistent with the role of these polymerases in replication of the lagging and the leading strands in human cells, respectively. Moreover, the direction of strand asymmetry observed in cancers with mutated polymerase delta is similar to that observed in MMR-deficient cancers. Together, these data indicate that polymerase delta (possibly together with polymerase alpha) contributes more mismatches during replication than its leading-strand counterpart, polymerase epsilon; that most of these mismatches are repaired by the MMR system; and that MMR repairs about three times more mismatches produced in cells during lagging strand replication compared with the leading strand.

摘要

错配修复(MMR)是维持复制保真度的主要系统之一。在酵母和人类癌症中已经报道了在复制前导链和滞后链时产生的错误的校正存在差异,但这些差异的原因仍不清楚。在这里,我们分析了在两种主要 DNA 聚合酶(delta 和 epsilon)中具有体细胞突变的人类癌症的数据,这些聚合酶复制基因组。我们表明,这些癌症在前导链和滞后链之间的突变存在显著的不对称性。这种不对称性的方向在具有突变聚合酶 delta 和 epsilon 的癌症之间是相反的,这与这些聚合酶在人类细胞中分别复制滞后链和前导链的作用一致。此外,在具有突变聚合酶 delta 的癌症中观察到的链不对称性的方向与 MMR 缺陷型癌症中观察到的方向相似。这些数据表明,聚合酶 delta(可能与聚合酶 alpha 一起)在复制过程中产生的错配比其前导链对应物聚合酶 epsilon 更多;这些错配中的大多数由 MMR 系统修复;并且 MMR 在滞后链复制过程中修复的错配比前导链多三倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/5538550/0f076f3ad4ea/1336f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验